One Step at a Time: Implementing Pathways to Optimize the Care of Geriatric Surgical Patients Alexandra Briggs ASO Perspectives 02 June 2022 Pages: 4655 - 4658
Personal Systemic Therapy Decision-Making has Officially Arrived for Node-Positive Breast Cancer Theresa Schwartz ASO Perspectives 16 April 2022 Pages: 4659 - 4662
The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer Judy C. BougheySarah L. BlairKelly K. Hunt ASO Perspectives 16 May 2022 Pages: 4663 - 4666
A Woman Needs to Know She Is a BRCA Carrier Before She Develops Breast Cancer Kevin S. HughesKanhua Yin Breast Oncology 12 May 2022 Pages: 4667 - 4669
Updates to the Literature on Anastomotic Leaks After Rectosigmoid Resection for Gynecologic Malignancies Lea A. MoukarzelOliver Zivanovic Gynecologic Oncology 18 May 2022 Pages: 4670 - 4672
Treatment of Oligometastatic Esophagogastric Cancer: A Spark of Light at the End of the Tunnel Lucas Goense Gastrointestinal Oncology 14 June 2022 Pages: 4673 - 4675
An Editorial on Lymphadenectomy in Esophagectomy for Cancer B. Feike KingmaJelle P. RuurdaRichard van Hillegersberg Thoracic Oncology 30 April 2022 Pages: 4676 - 4678
The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations Jessica S. Donington Thoracic Oncology 06 May 2022 Pages: 4679 - 4680
Association of the Modified Albumin–Bilirubin Grade with Survival Outcomes in Esophageal Squamous Cell Carcinoma Yi-Min GuHan-Lu ZhangLong-Qi Chen Thoracic Oncology 09 May 2022 Pages: 4681 - 4682
Invited Editorial: Comprehensive Analysis of Molecular Biological Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm Ippei Matsumoto Pancreatic Tumors 13 April 2022 Pages: 4683 - 4685
A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) Martha E. TekeAmber Leila SarvestaniRobert D. Timmerman ASO Research Letter 06 May 2022 Pages: 4686 - 4687
Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR) Tahsin M. KhanEmily A. VerbusYasir Y. Elamin ASO Research Letter 09 May 2022 Pages: 4688 - 4689
The Association of Frailty with Outcomes after Cancer Surgery: A Systematic Review and Metaanalysis Julia F. ShawDan BudianskyDaniel I. McIsaac Global Health Services Research 24 January 2022 Pages: 4690 - 4704
ASO Visual Abstract: The Association of Frailty with Outcomes After Cancer Surgery—A Systematic Review and Meta-Analysis Julia F. ShawDan BudianskyDaniel I McIsaac ASO Visual Abstract 16 April 2022 Pages: 4705 - 4705
Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy Sarah ShubeckVaradan SevilimeduMelissa L. Pilewskie Breast Oncology 18 May 2022 Pages: 4706 - 4713
ASO Visual Abstract: Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery and Those Treated With Mastectomy Sarah ShubeckVaradan SevilimeduMelissa L. Pilewskie ASO Visual Abstract 05 June 2022 Pages: 4714 - 4715
Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease Miquel Ensenyat-MendezDennis RüngerMaggie L. DiNome Breast Oncology 09 April 2022 Pages: 4716 - 4724
ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla Maggie L. DiNomeDiego M. Marzese ASO Author Reflections 12 April 2022 Pages: 4725 - 4726
ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease Miquel Ensenyat-MendezDennis RüngerMaggie L. DiNome ASO Visual Abstract 16 April 2022 Pages: 4727 - 4727
Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality Lindsay J. CollinKatie Ross-DriscollLauren E. McCullough Breast Oncology 18 April 2022 Pages: 4728 - 4738
ASO Visual Abstract: Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality: Delay, Facilities, and Breast Cancer Mortality Lindsay J. CollinKatie Ross-DriscollLauren E. McCullough ASO Visual Abstract 26 April 2022 Pages: 4739 - 4739
Contemporary Axillary Management in cT1–2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database Arielle P. StaffordTanya L. HoskinJudy C. Boughey Breast Oncology 22 April 2022 Pages: 4740 - 4749
ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden Arielle P. StaffordTanya L. HoskinJudy C. Boughey ASO Author Reflections 27 April 2022 Pages: 4750 - 4751
ASO Visual Abstract: Contemporary Axillary Management in cT1-2N0 Breast Cancer with 1–2 Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database Arielle P. StaffordTanya L. HoskinJudy C. Boughey ASO Visual Abstract 28 April 2022 Pages: 4752 - 4752
Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy Regina MatarVaradan SevilimeduMonica Morrow Breast Oncology 24 April 2022 Pages: 4753 - 4760
ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence Regina MatarMonica Morrow ASO Author Reflections 22 April 2022 Pages: 4761 - 4762
ASO Visual Abstract: Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women With Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy Regina MatarVaradan SevilimeduMonica Morrow ASO Visual Abstract 02 May 2022 Pages: 4763 - 4763
Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy? Julia Caroline RadosaErich-Franz SolomayerChristoph Georg Radosa Breast Oncology Open access 29 April 2022 Pages: 4764 - 4772
ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria Julia Caroline RadosaErich-Franz SolomayerChristoph Georg Radosa ASO Author Reflections Open access 29 April 2022 Pages: 4773 - 4774
ASO Visual Abstract: Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: An Alternative to Sentinel-Node-Biopsy? Julia Caroline RadosaErich-Franz SolomayerChristoph Georg Radosa ASO Visual Abstract 12 May 2022 Pages: 4775 - 4776
The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA) Alberto E. ArdonJohn E. George IIIRoy A. Greengrass Breast Oncology 15 April 2022 Pages: 4777 - 4786
ASO Author Reflections: SAMBA’s Practice Advisory for the Use of Pectoralis Blocks in Breast Surgery: Overview and Lingering Questions Alberto E. ArdonJohn E. George IIIRoy A. Greengrass ASO Author Reflections 12 April 2022 Pages: 4787 - 4788
ASO Visual Abstract: The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review From the Society for Ambulatory Anesthesia (SAMBA) Alberto E. ArdonJohn E. George IIIRoy A. Greengrass ASO Visual Abstract 12 May 2022 Pages: 4789 - 4790
Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience Barbara CostantiniVirginia VargiuAnna Fagotti Gynecologic Oncology Open access 18 April 2022 Pages: 4791 - 4802
ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery—What We Know and Future Perspectives Virginia VargiuFrancesco SantulloAnna Fagotti ASO Author Reflections 16 April 2022 Pages: 4803 - 4804
ASO Visual Abstract: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A large Single-Center Experience Barbara CostantiniVirginia VargiuAnna Fagotti ASO Visual Abstract 28 April 2022 Pages: 4805 - 4805
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study Alex FedericoLuigi Pedone AnchoraGabriella Ferrandina Gynecologic Oncology Open access 30 March 2022 Pages: 4806 - 4814
ASO Author Reflections: Role of Adjuvant Surgery in Locally Advanced Cervical Cancer: An Unresolved Issue A. FedericoL. Pedone AnchoraG. Ferrandina ASO Author Reflections 02 April 2022 Pages: 4815 - 4816
ASO Visual Abstract: Clinical Impact of Pathological Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study Alex FedericoLuigi Pedone AnchoraGabriella Ferrandina ASO Visual Abstract 09 April 2022 Pages: 4817 - 4818
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer Nabil ManzourLuis ChivaOn behalf of the SUCCOR Study Group Gynecologic Oncology Open access 16 April 2022 Pages: 4819 - 4829
ASO Author Reflections: Will Conization Become a Standard Maneuver Before Radical Hysterectomy? Luis ChivaNabil Manzour ASO Author Reflections 19 April 2022 Pages: 4830 - 4831
ASO Visual Abstract: SUCCOR Risk—Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer Nabil ManzourLuis Chivathe SUCCOR Study Group ASO Visual Abstract 15 May 2022 Pages: 4832 - 4832
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands G. M. Nieuwenhuyzen-de BoerW. HofhuisH. J. van Beekhuizen Gynecologic Oncology Open access 13 May 2022 Pages: 4833 - 4843
ASO Author Reflections: The PlasmaJet® Device Contributes to an Increase in the Number of Complete Cytoreductive Surgeries for Ovarian Cancer Patients G. M. Nieuwenhuyzen-de BoerH. J. van Beekhuizen ASO Author Reflections Open access 28 April 2022 Pages: 4844 - 4845
ASO Visual Abstract: The Role of Adjuvant Use of the PlasmaJet® Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer—Results of the PlaComOv-Study, a Randomized, Controlled Trial in the Netherlands G. M. Nieuwenhuyzen-de BoerW. HofhuisH. J. van Beekhuizen ASO Visual Abstract 14 June 2022 Pages: 4846 - 4847
Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer Tiuri E. KroeseGeorge S. BuijsRichard van Hillegersberg Thoracic Oncology Open access 05 April 2022 Pages: 4848 - 4857
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer Tiuri E. KroesePeter S. N. van RossumRichard van Hillegersberg ASO Author Reflections Open access 19 March 2022 Pages: 4858 - 4860
ASO Visual Abstract: Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer Tiuri E. KroeseGeorge S. BuijsRichard van Hillegersberg ASO Visual Abstract Open access 02 April 2022 Pages: 4861 - 4862
Selective Lymphadenectomy for Salvage Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma Shuhei MayanagiRyoma HanedaYasuhiro Tsubosa Thoracic Oncology 12 May 2022 Pages: 4863 - 4870
ASO Author Reflections: Safety and Curability of Lymphadenectomy for Salvage Esophagectomy Shuhei MayanagiRyoma HanedaYasuhiro Tsubosa ASO Author Reflections 11 May 2022 Pages: 4871 - 4871